To confirm the subtype-specific anti-metastatic capacity of FOXC1, we exogenously expressed FOXC1 in two different Luminal B human breast cancer cell lines and assayed invasiveness via a Boyden chamber assay. Here, FOXC1 is linked to breast carcinoma.